Page 93 - GTM-2-3

Global Translational Medicine HPLC-UV lacosamide quantification

8. Cawello W, Boekens H, Bonn R, 2012, Absorption, 2022 Sep 12].
disposition, metabolic fate and elimination of the anti- 17. Argentina ANMAT, 2013, Disposición 4394/2013 Buenas
epileptic drug lacosamide in humans: Mass balance Prácticas de Laboratorio. https://www.argentina.gob.ar/
following intravenous and oral administration. Eur J Drug normativa/nacional/disposici%C3%B3n-4394-2013-217492
Metab Pharmacokinet, 37: 241–248.
[Last accessed on 2022 Sep 12].
https://doi.org/10.1007/s13318-012-0093-x 18. R Core Team, 2018, R: A Language and Environment
9. Schultz L, Mahmoud SH, 2020, Is therapeutic drug for Statistical Computing, R Foundation for Statistical
monitoring of lacosamide needed in patients with seizures Computing, Vienna, Austria. Available from: https://
and epilepsy? Eur J Drug Metab Pharmacokinet, 45: 315–349. www.R-project.org/ [Last accessed on 2023 Mar 15].
https://doi.org/10.1007/s13318-019-00601-8 19. Caballero RR, González RA, Lavaut JA, 1998, Propranolol
y sus ésteres: Detección y resolución enantiomérica
10. Greenaway C, Ratnaraj N, Sander JW, et al., 2010, A high- (Propranolol and its esters: detection and enantiomeric
performance liquid chromatography assay to monitor the resolution). Rev Cuba Farm, 32: 130–139. (Article in Spanish)
new antiepileptic drug lacosamide in patients with epilepsy.
Ther Drug Monit, 32: 448–452. 20. Dong MH, 2019, HPLC and UHPLC for Practicing
Scientists. 2 ed. Hoboken NY: John Wiley and Sons, Inc.
nd
https://doi.org/10.1097/FTD.0b013e3181dcc5fb
21. Gonçalves J, Alves G, Bicker J, et al., 2018, Development
11. Valarmathi R, Banu SF, Akilandeswari S, 2013, A review and full validation of an innovative HPLC-diode array
on new antiepileptic drug-lacosamide and its analytical detection technique to simultaneously quantify lacosamide,
methods. Int J Pham Chem Sci, 2: 181–186. levetiracetam and zonisamide in human plasma. Bioanalysis,
12. Nazma S, Yasaswini M, Sai Supraja M, et al., 2015, 10: 541–557.
Development and validation of RP-HPLC method for the https://doi.org/10.4155/bio-2017-0199
estimation of lacosamide in bulk and parenteral dosage
form. Int J Res Pharm Chem, 5: 355–360. 22. Kestelyn C, Lastelle M, Higuet N, et al., 2011, A simple
HPLC-UV method for the determination of lacosamide in
13. Sreenivasulu V, Rao DR, Maheswar U, et al., 2011, human plasma. Bioanalysis, 3: 2515–2522.
Development and validation of a stability-indicating
RP-HPLC method for determination of lacosamide. Res J https://doi.org/10.4155/bio.11.261
Pharm Biol Chem Sci, 2: 1–11. 23. Lipecki Y, Haen E, 2022, Simultaneous quantification of
14. United State Pharmacopeia, 2022, National Formulary 38 11 antiseizure medications and metabolites in serum for
(USP 43/2019 NF 38)-General Chapter 621 Chromatography. therapeutic drug monitoring using high-performance
Available from: https://www.usp.org/sites/default/files/usp/ liquid chromatography with ultraviolet detection: A short
document/harmonization/gen-chapter/harmonization- communication. Ther Drug Monit, 44: 345–350.
november-2021-m99380.pdf [Last accessed on 2023 Jan 21]. https://doi.org/10.1097/FTD.0000000000000908
15. USA Food and Drug Administration (FDA), 2018, 24. Carona A, Bicker J, Silva R, et al., 2021, HPLC method for
Guidance for Industry Bioanalytical Method Validation. the determination of antiepileptic drugs in human saliva
Available from: https://www.fda.gov/files/drugs/published/ and its application in therapeutic drug monitoring. J Pharm
Bioanalytical-Method-Validation-Guidance-for-Industry. Biomed Anal, 197: 113961.
pdf [Last accessed on 2022 Jan 03].
https://doi.org/10.1016/j.jpba.2021.113961
16. International Conference on Harmonization: ICH
Harmonized Tripartite Guideline, 2021, Q2 (R1) 25. Mohamed FA, Ali MF, Rageh AH, et al., 2019, Highly sensitive
Validation of Analytical Procedures: Text and Metodology, UHPLC-DAD method for simultaneous determination of
Guidance for Industry. Available from: https://www. two synergistically acting antiepileptic drugs; levetiracetam
fda.gov/regulatory-information/search-fda-guidance- and lacosamide: Application to pharmaceutical tablets and
documents/q2r1-validation-analytical-procedures-text- human urine. Biomed Chromatogr, 33: e4554.
and-methodology-guidance-industry [Last accessed on https://doi.org/10.1002/bmc.4554

Volume 2 Issue 3 (2023) 11 https://doi.org/10.36922/gtm.1265